Dear Molecular Imaging Insider,
PET/CT has gradually emerged as an important imaging modality in cases of non-small cell lung cancer. It's become evident that the hybrid technique can boost understanding of biological mechanisms involved in lung tumor cells, leading to a better selection of treatment modalities for patients and a better prognosis.
The latest research findings from the Medical University of Vienna look set to add further momentum to this trend. You can find out more in today's article.
In this week's second article, nuclear medicine specialists claim they were not adequately consulted in clinical practice guidelines for thyroid nodule management. They refer to "the marginalization of nuclear medicine" and "the surprising downgrading of radioiodine (and surgery) ... despite more than 80 years of successful application."
There's much discussion right now about the potential clinical applications of ChatGPT. For instance, does the AI tool have a role in helping to prepare patients for imaging exams and increase their understanding of reports? We checked in with two nuclear medicine physicians at the Charité in Berlin. Don't miss our video interview.
In other news, Swiss authors have conducted a feasibility study that may revive interest in SPECT seizure imaging as a way of helping neurosurgeons guide brain surgery in epilepsy patients.
Czech investigators, meanwhile, have reported that PET/MRI shows promise in diagnosing fevers or inflammation of unknown origin and may have advantages over PET/CT.
Philip Ward
Editor in Chief
AuntMinnieEurope.com
